Vrati se na sadržaj

Hematologija

Aplastična anemija

Eltrombopag added to immunosuppression in severe aplastic anemia. (otvara novi prozor)

Peffault de Latour R, Kulasekararaj A, Iacobelli S, Terwel SR, Cook R, Griffin M, Halkes CJM, Recher C, Barraco F, Forcade E, Vallejo JC, Drexler B, Mear JB, Smith AE, Angelucci E, Raymakers RAP, de Groot MR, Daguindau E, Nur E, Barcellini W, Russell NH, Terriou L, Iori AP, La Rocca U, Sureda A, Sánchez-Ortega I, Xicoy B, Jarque I, Cavenagh J, Sicre de Fontbrune F, Marotta S, Munir T, Tjon JML, Tavitian S, Praire A, Clement L, Rabian F, Marano L, Hill A, Palmisani E, Muus P, Cacace F, Frieri C, van Lint MT, Passweg JR, Marsh JCW, Socié G, Mufti GJ, Dufour C, Risitano AM; Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation

Izvor‎: N Engl J Med 2022;386(1):11-23.

Indeks‎: PubMed 34986284

DOI‎: 10.1056/NEJMoa2109965

https://pubmed.ncbi.nlm.nih.gov/34986284/ (otvara novi prozor)

Eltrombopag added to standard immunosuppression for aplastic anemia. (otvara novi prozor)

Townsley DM, Scheinberg P, Winkler T, Desmond R, Dumitriu B, Rios O, Weinstein B, Valdez J, Lotter J, Feng X, Desierto M, Leuva H, Bevans M, Wu C, Larochelle A, Calvo KR, Dunbar CE, Young NS

Izvor‎: N Engl J Med 2017;376(16):1540-50.

Indeks‎: PubMed 28423296

DOI‎: 10.1056/NEJMoa1613878

https://www.ncbi.nlm.nih.gov/pubmed/28423296 (otvara novi prozor)